September 30, 2011 – PACSGear announced an expanded strategy to combine medical images from all departments with electronic health records (EHR). The “PACS 2.0” initiative is the evolution of medical image connectivity to include integration with the electronic health record.

September 30, 2011 – Siemens Healthcare returns to the Annual Meeting of the American Society for Radiation Oncology (ASTRO), Oct. 2-6 in Miami, with a broad range of solutions that multiply chances – for life. At this year’s booth (#203), Siemens will demonstrate its strong commitment to battling cancer with a portfolio that covers the spectrum of oncology care, with a particularly strong focus on diagnostic oncology imaging in in-room and outside-the-room imaging as well as in radiation therapy.

September 30, 2011 – The Molecular Imaging Biomarker Research Group of Siemens Medical Solutions recently completed a Phase II multi-center clinical trial of its HX4 positron emission tomography (PET) imaging biomarker, which is designed to detect hypoxia – a reduction in tissue oxygen levels – in solid tumors. The trial’s primary objective was to test the reproducibility of HX4’s uptake in tumors by conducting PET/computed tomography (CT) scans of the same patient on sequential days in a test-retest protocol. The trial enrolled 40 patients with head and neck, lung, liver, rectal or cervical cancers, who were scheduled to receive chemotherapy, radiation therapy or a combination of the two.

September 30, 2011 – ViewRay Inc. will present potential applications for magnetic resonance imaging (MRI)-guided radiotherapy at the annual meeting of the American Society for Radiation Oncology (ASTRO) Oct. 2-4 in Miami Beach, Fla., with software demonstrations in booth #865. The company's new research radiation therapy system is being developed to feature a patented combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI). The system is being designed to let radiation oncologists see what they're treating, while they're treating.

September 28, 2011 – Researchers have a new weapon in their arsenal to diagnose and treat traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) among military service members and civilians. The National Institutes of Health Clinical Center began imaging patients last week on a first-of-its-kind, whole-body simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) device. The Biograph mMR offers a more complete picture of abnormal metabolic activity in a shorter time frame than separate MRI and PET scans, two tests many patients undergo.

September 28, 2011 ­– Hie Electronics, a manufacturer of long-term scalable Active Archive data storage solutions and the manufacturer of the TeraStack Solution, announced that it has received a registration with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health.

September 28, 2011 – Bionix Radiation Therapy announces the addition of Breath Hold, an interactive breath-hold control monitoring system from MedSpira, as an accessory to its Omni V Patient Positioning System. Developed by Mayo Clinic physicians, Breath Hold is a user-friendly system that enables patients to easily and consistently reproduce a breath-hold reference point consistent breathing pattern. This consistency is a significant benefit, ideal for stereotactic radiation therapy procedures involving the lungs and upper abdomen.

September 28, 2011 – Calypso Medical Technologies Inc., developer of real-time localization technology used for precise tumor tracking, announced that the U.S. Food and Drug Administration (FDA) granted investigational device exemption (IDE) approval for its clinical study evaluating real-time tracking of lung cancer tumors during radiation delivery. Patient enrollment is planned at Washington University in St. Louis, and the Cancer Treatment Centers of America in Tulsa, Oklahoma. Investigators in the United States will implant three anchored Beacon transponders in patients’ lungs and use the Calypso System to precisely track tumor location and movement during lung cancer radiation therapy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now